Systemic inflammation is associated with inferior disease control and survival in stage III non-small cell lung cancer

BACKGROUND: The systemic immune-inflammation index (SII) correlates with patient survival in various types of solid malignancies, including non-small cell lung cancer (NSCLC). However, limited information is available on the prognostic implication and disease-specific survival of SII in patients und...

Descripción completa

Detalles Bibliográficos
Autores principales: Keit, Emily, Coutu, Brendan, Zhen, Weining, Zhang, Chi, Lin, Chi, Bennion, Nathan, Ganti, Apar Kishor, Ernani, Vinicius, Baine, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940875/
https://www.ncbi.nlm.nih.gov/pubmed/33708854
http://dx.doi.org/10.21037/atm-20-6710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940875/
https://www.ncbi.nlm.nih.gov/pubmed/33708854
http://dx.doi.org/10.21037/atm-20-6710

Ejemplares similares